Stein, E., Issa, G. C., Rego, E. M., Fukushima, K., Kühn, M. W. M., Fleming, S., Smith, A. R., Vyas, P. (2026). A phase 3 study of revumenib in combination with intensive chemotherapy in patients with newly diagnosed NPM1 -mutated acute myeloid leukemia (REVEAL-ND NPM1).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps6602